Predicting corticosteroid-free endoscopic remission with vedolizumab in ulcerative colitis.
| Author | |
|---|---|
| Abstract |
:
Vedolizumab is an effective therapy for ulcerative colitis (UC), but costly and slow to work. New clinical responses occur after 30 weeks of therapy. |
| Year of Publication |
:
2018
|
| Journal |
:
Alimentary pharmacology & therapeutics
|
| Date Published |
:
2018
|
| ISSN Number |
:
0269-2813
|
| URL |
:
http://dx.doi.org/10.1111/apt.14510
|
| DOI |
:
10.1111/apt.14510
|
| Short Title |
:
Aliment Pharmacol Ther
|
| Download citation |
